Details

NameSymbolSector
MANKIND PHARMA LIMITEDMANKINDPharmaceuticals
Open
2349.9
High
2354.4
Low
2268.7
Close
2275.5
Volume
889731
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

0.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Mankind Pharma is  
Marubozu
Estimated Stoploss of Mankind Pharma is ₹  
2354.4
Mankind Pharma has a  
Bearishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Mankind Pharma has chances of  
Continuationℹ
 of the current trend. 

Trend

Mankind Pharma is in  
Sideways trendℹ
. 
Price of Mankind Pharma is  
Downℹ
 by  

5.86

%. 
Target
Buy @ 

2271.33

Sell @ 

2624.27

Current @ 

2275.5

Volume

The trades of Mankind Pharma have been in  
Immenseℹ
 volume. 
The volume trades for Mankind Pharma are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Mankind Pharma is  

Up

 by  

99.33

% 

Valuation

The current market price of Mankind Pharma is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 27759cr and total assets worth ₹ 27759cr, the balance sheet of Mankind Pharma is:  
Balancedℹ
. 
Cashflow
Mankind Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 21cr

. It is  
Downℹ
 by  

72.73

%. 

(*Mar 2025)

9.51% i.e. ₹ 2413cr earned in operatingℹ
49.96% i.e. ₹ 12682cr spent in investingℹ
40.31% i.e. ₹ 10232cr earned in financingℹ
0.23% i.e. ₹ 58cr earned in otherℹ
Mankind Pharma has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 77cr

. It is  
Upℹ
 by  

266.67

%. 

(*Mar 2024)

50.77% i.e. ₹ 2152cr earned in operatingℹ
49.09% i.e. ₹ 2081cr spent in investingℹ
0.12% i.e. ₹ 5cr earned in financingℹ
0.02% i.e. ₹ 1cr earned in otherℹ
Income
The income of Mankind Pharma is  

₹ 3789cr

 and  

Profit

 is :  

₹ 517cr

(*Sep 2025)

Mankind Pharma Profit is up by:  

4.5

% and Income is Up by:  

9.61

% 

(*Sep 2025)

The income of Mankind Pharma is  

₹ 3650cr

 and  

Profit

 is :  

₹ 441cr

(*Jun 2025)

Mankind Pharma Profit is up by:  

10.76

% and Income is Up by:  

0.7

% 

(*Jun 2025)

The income of Mankind Pharma is  

₹ 3330cr

 and  

Profit

 is :  

₹ 422cr

(*Mar 2025)

Mankind Pharma Profit is down by:  

41.92

% and Income is Up by:  

3.83

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.